| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Schmidt David serves as a Director at ASTH. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $1.5M at current prices.
The biggest single holding is ASTH (~$1.5M) as Director. The recent filings there lean toward selling, a net 40,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | ASTH Astrana Health, Inc. | Director | Sale+OE | 40,000 | $73.67 | $2,946,800.00 | -100% | +59.0% | -36.4% |